Green Cross will build a manufacturing factory for cell therapy products, showing active movements in China

Targeting the rapidly growing Chinese market, Green Cross is going to build a manufacturing facility for cell therapy products.

Green Cross Holdings (CEO Byung-gun Lee) announced that its Hong Kong branch, Green Cross HK Holdings (hereinafter referring to GCHK), has made a formal contract with the Guizhou Guian New Town Governing Committee to invest in the cell therapy product business on the ...